Member Benefits by Sector: Health
BIO is a global community encouraging investment and promoting policies that support innovation. BIO members are leading the research and development of innovative healthcare treatments and cures.
BIO advocates on behalf of our members on existing and future drug coverage programs - including Medicare and Medicaid, the 340B program, ACA exchanges, rebate programs, and more.
BIO develops and implements strategic responses to scientific and regulatory initiatives from the FDA, NIH, and others; addressing issues that affect the ability of BIO's human healthcare-focused companies to research and develop new medicines and biotechnology therapies, and to bring these products to market.
BIO works with government agencies to address vaccine policy and regulatory reform, biodefense preparedness, antimicrobial resistance, and the growth of personalized medicine products.
"As a BIO member, we have access to a network of peers and experts that can help us address policy matters, particularly around key issues relevant to our business, like Medicare reimbursement. In the CAR T space, this is critical to help advance patient access to potentially life-saving medicines, regardless of age or socio-economic status."
Chief Executive Officer